Please contact us for more information or to learn if you are eligible to participate.
The purpose of this research study is to evaluate the efficacy and safety of the drugs dapagliflozin and saxagliptin in patients with Type 2 Diabetes who are aged 10 to below 18 years old and are currently taking metformin, insulin, or both drugs.
Principal Investigator | Marcel Twahirwa, MD |
Type of Trial | Prospective |